Back to search

Article

Optimizing the timing of one or two doses of pneumococcal conjugate vaccines in older adults in the United States: a modeling study

2025-10-27

Abstract excerpt

<h4>Background</h4> Older adults have a high burden of pneumococcal disease. Pneumococcal conjugate vaccines (PCVs) are effective in reducing disease risk. Recent changes to lower recommended age of pneumococcal vaccination among PCV-naïve adults by the United States (US) Centers for Disease Control and Prevention (CDC) raises important questions on the optimal age of pneumococcal vaccination, as well as revaccin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7eaac9a8-c6ac-5851-a754-1d1bf7d01e82
DOI
10.1101/2025.10.24.25338736
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing the timing of one or two doses of pneumococcal conjugate vaccines in older adults in the United States: a modeling studyDOI 10.1101/2025.10.24.25338736
The impact of vaccine products, schedules and geographic regions on immunogenicity of pneumococcal vaccines in children under 2 years old: a systematic review and meta-analysisSemantic proximity
Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infectionsSemantic proximity
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity
A model-based evaluation of the cost-effectiveness of paediatric and elderly vaccination against pneumococcal infection in EnglandSemantic proximity
Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccinesSemantic proximity
Pneumococcal Meningitis in Adults in 2014-2018 After Introduction of Pediatric 13-valent Pneumococcal Conjugate Vaccine in JapanSemantic proximity
Validation of methods for forecasting the frequency of non-vaccine serotypes after introduction or switch of a pneumococcal conjugate vaccineSemantic proximity
Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan.Semantic proximity
Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older AdultsSemantic proximity
Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine program in Malawi, a modelling studySemantic proximity
Risk factors for invasive pneumococcal disease in adults: a systematic review and meta-analysisSemantic proximity
Comprehensive vaccine design for commensal disease progressionSemantic proximity
Select a neighboring publication to make it the new centre.